Blog
You'll Definitely Regret Delaying Social Security Until 70 If This Happens
Delaying your claim for Social Security until the age of 70 is often the right financial move. Many financial experts agree it makes sense to wait to get benefits because delaying maximizes monthly
Is Etsy Still Unstoppable After a Major Sell-Off?
Etsy (NASDAQ: ETSY), the online marketplace that specializes in handmade and vintage goods, disappointed investors when it announced first-quarter results on May 5.
Although revenue and net income
Moderna's Vaccine Produces Antibodies for at Least 6 Months
Moderna (NASDAQ: MRNA) reported data showing participants in its coronavirus vaccine trial continued to have antibodies to the virus six months later. In this video from Motley Fool Live, recorded
3 Stocks That Are Absurdly Cheap Right Now
With many financial headlines describing "frothy" markets at or near "all-time highs," investors may think most stocks are extremely expensive. But in every market, there's usually something out
3 Steps to Making Millions in the Stock Market
A lot of people regard the stock market as a scary, unpredictable thing, but actually, stocks have a long history of delivering solid returns. As such, investing in stocks is a good way to turn
3 ETFs That Can Make You Rich
For more than a year, volatility has been a way of life for investors. The uncertainty brought about by the coronavirus pandemic ultimately sent the CBOE Volatility Index, which measures the
3 Cathie Wood Stocks That Could Deliver Bigger Gains Than Dogecoin
Brace yourself for an even greater buzz for Dogecoin (CRYPTO: DOGE) after Elon Musk hosted Saturday Night Live over the weekend. Musk is one of the most visible -- and vocal -- fans of the
3 Robinhood Stocks With High Dividend Yields
You'll find quite a bit of variety when you look at the 100 most popular stocks on Robinhood. There are several meme stocks. Plenty of pot stocks. A boatload of tech stocks. And, yes, Robinhood
5 Growth Stocks Rocketing Up My Prospective Buy List
Approximately 13.5 months ago, uncertainty on Wall Street hit its peak and the benchmark S&P 500 bottomed out. Since hitting its trough on March 23, 2020, it's returned as much as 88%, not including
3 Ways Your Employer Could Mess Up Your 401(k)
Saving for retirement in a 401(k) is kind of like hiring a contractor to build your house. You define the scope of the project, provide the financing, and ultimately get to enjoy the end result, but
Sorry to Say: You Probably Shouldn't Claim Social Security at 62
You have choices when it comes to signing up for Social Security. Many seniors opt to claim their benefits at full retirement age, or FRA. That age is either 66, 67, or somewhere in between
Why MakeMyTrip Stock Fell 13.2% Last Month
Shares of MakeMyTrip (NASDAQ: MMYT) dipped 13.2% in April, according to data from S&P Global Market Intelligence. India faced surging COVID-19 infections and deaths, and it's not surprising that the
Got $5,000? 2 Tech Stocks to Buy and Hold For the Long Term
Many investors look at Amazon and wish they had bought its stock when the company sold only books. And they will often set their sights on finding the "next Amazon."
While finding superstars at an
Is Generic-Drug Maker Viatris a Keeper?
In this video from Motley Fool Live, recorded on April 5, Fool.com Contributors Brian Orelli and Keith Speights discuss a question from a member named Angel, who asks whether Viatris (NASDAQ: VTRS)
Clearance? Approval? What Should Investors Make of Nano-X's FDA Decision?
Last month, Nano-X Imaging (NASDAQ: NNOX) gained 501(k) clearance from the Food and Drug Administration (FDA) for its X-ray device. In this video from Motley Fool Live, recorded on April 5, Fool.com
Why Shares of Chart Industries Climbed 13% in April
Falling more than 9% through the first three weeks of April, shares of Chart Industries (NYSE: GTLS) weren't giving investors much to celebrate -- especially since the S&P 500 had risen more than 4%
Some Prominent Doctors Continue to Shun Biogen's Alzheimer's Drug
Biogen (NASDAQ: BIIB) will get a decision on Alzheimer's disease drug aducanumab next month, but a recent op-ed by members of the Food and Drug Administration (FDA) advisory committee that reviewed
Is Vaccine Maker Vaxart Worth Holding From Here?
Shares of vaccine expert Vaxart (NASDAQ: VXRT) have gone on a wild ride over the past 12 months as the company has released data for its coronavirus vaccine. In this video from Motley Fool Live
Why Is GlaxoSmithKline Selling Its Income Stream to Royalty Pharma?
GlaxoSmithKline (NYSE: GSK) announced plans to sell the royalties it receives on sales of Exelixis' (NASDAQ: EXEL) Cabometyx and Cometriq to Royalty Pharma (NASDAQ: RPRX). In this video from Motley
American Airlines Courts Danger With Partnership Strategy
Despite being the largest U.S. airline by many metrics, American Airlines (NASDAQ: AAL) had some glaring strategic weaknesses even before the COVID-19 pandemic crushed the industry last year.
First
Why First Solar, Sunrun, and SunPower Fell by as Much as 23.2% in April
Shares of First Solar (NASDAQ: FSLR), Sunrun (NASDAQ: RUN), and SunPower (NASDAQ: SPWR) fell 12.3%, 19%, and 23.2%, respectively, in April, according to data from S&P Global Market Intelligence. At
Is Now the Time to Invest in Renewable Energy Stocks?
No one said investing was easy, and that's definitely the case with the renewable energy sector right now. The long-term outlook remains very positive, but I think investors should be stock
How Much Is BioNTech's Increased Vaccine Production Really Worth?
BioNTech (NASDAQ: BNTX) recently raised guidance for the number of doses of its coronavirus vaccine that the biotech thinks it'll be able to produce this year. In this video from Motley Fool Live
3 Impressive Tech Earnings Reports Last Week
It was a wild week for tech. Growth stocks were slammed throughout most of the week. Though they recovered some ground on Monday, as the Nasdaq Composite rose about 1%. Despite weakness in growth
3 Best Gold Stocks to Buy Right Now
Gold prices have declined steadily this year after a heady run-up in 2020. That's driven some investors out of gold stocks, but those in the know will consider such times as opportunities to park


